Navigation Links
Legislation Would Deny Floridians Access to Needed Medicines from Their Trusted Independent Community Pharmacies, and Instead Favor Publicly Traded Chain Pharmacies

ALEXANDRIA, Va., March 31, 2011 /PRNewswire-USNewswire/ -- National Community Pharmacists Association Executive Vice President and CEO Kathleen Jaeger issued the following statement today in response to the Florida House Judicial Committee's passage of HB 7095, legislation sponsored by State Rep. Rob Schenck, and in particular an amendment that would restrict the dispensing of controlled substances on Schedule II and Schedule III to publicly traded pharmacy chains or only those independent community pharmacies that have been in business more than 10 years:


"We all support efforts to keep illegal substances out of the hands of those who are addicted to drugs. However, as good as Representative Schenck's intentions may be, this legislation would result in keeping medicines from actual patients who need them.  In essence, it would make real patients and independent community pharmacies collateral damage between the War on Drugs and the War on Pain.

"This bill is misguided, and does a great disservice to patients under the guise of drug diversion. There is no credible evidence to suggest that drug diversion occurs at a higher level in independent community pharmacies than that of chains. Creating an uneven competitive playing field does nothing to advance the resolution of the underlying drug diversion issue, and forces many patients to leave their trusted independent community pharmacist to obtain their prescriptions at chain pharmacies. This is particularly a problem in underserved rural and urban communities, where independent pharmacists may be the only health care provider available. Under this bill, these patients with legitimate health needs will be denied timely access to essential medications.

"In addition, with Florida's unemployment rate at 11.5 percent and state leaders grappling with crippling revenue shortfalls, it would be incredibly short-sighted for the legislature to put its thumb on the scales against local, family owned pharmacies. Florida's 1,303 independent community pharmacies are pillars of their communities, employing 13,942 Floridians and indirectly supporting many more jobs. This legislation would undermine those jobs at the worst possible time by sending Florida dollars out of state via the nearest Big Box chain pharmacy.

"On behalf of patients with real health needs, independent community pharmacists will work vigorously to defeat this misguided proposal. In the meantime, we look forward to working cooperatively with state leaders on reasonable solutions to combat the abuse of controlled substances."

The National Community Pharmacists Association (NCPA®) represents the interests of America's community pharmacists, including the owners of more than 23,000 independent community pharmacies, pharmacy franchises, and chains. Together they represent a $93 billion health-care marketplace, have more than 315,000 employees including 62,400 pharmacists, and dispense over 41% of all retail prescriptions. To learn more go to or read NCPA's blog, The Dose, at

SOURCE National Community Pharmacists Association
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. California Legislature Passes Historic HIV Testing Bill (AB 682); AHF Urges Governor to Sign Crucial Lifesaving Legislation
2. New Legislation Seeks to Boost Participation in Clinical Trials for Rare Diseases
3. Control Risks Forecasts New Reality for Business in 2011 Brought by Emerging Markets, Legislation
4. Bi-Partisan Legislation Introduced Would Repeal Controversial Medicare Competitive Bidding Requirements for Home Medical Equipment
5. Organ Donor Shortage Remains Obstacle for Would-Be Transplant Patients Despite Better Medicine
6. A Drug With Efficacy Superior to That of Xenical at Inducing Weight Loss Would Earn a 40 Percent Patient Share in the Obesity Drug Market
7. A First-Line Therapy for Renal Cell Carcinoma that can Increase Overall Survival when Compared with Sutent Would Earn a Higher Patient Share in the United States Than in Europe
8. New Federal Stem Cell Rules Would Hinder Existing Research, Consumer Group Warns
9. For Breast Cancer Treatment, an Agent That Can Achieve an Overall Survival Benefit Would Pose the Greatest Challenge to Avastins Dominance in Europe
10. An Acute Migraine Therapy That is Not Contraindicated in Patients With a History of Vascular Disease Would Earn a 45 Percent Patient Share in the United States, According to Surveyed Neurologists
11. Three in Ten Americans Would Use Their Cell Phone to Track Personal Health, Finds PricewaterhouseCoopers
Post Your Comments:
(Date:6/24/2016)... Mass. , June 24, 2016   ... Spaulding Rehabilitation Network,s Dean Center for Tick ... Physical Medicine and Rehabilitation, MIT Hacking Medicine, University ... for Innovation, today announced the five finalists of ... for Lyme disease.  More than 100 scientists, clinicians, ...
(Date:6/24/2016)... , June 24, 2016 The Academy of ... recommendations that would allow biopharmaceutical companies to ... entities that make formulary and coverage decisions, a move ... of new medicines. The recommendations address restrictions ... appear on the drug label, a prohibition that hinders ...
(Date:6/24/2016)... Research and Markets has announced the addition of ... report to their offering. ... The World Market for Companion Diagnostics covers the world market ... the report includes the following: , World ... Region (N. America, EU, ROW), 2015-2020 , World IVD ...
Breaking Medicine Technology:
(Date:6/25/2016)... ... June 25, 2016 , ... Conventional wisdom preaches the ... In terms of the latter, setting the bar too high can result in disappointment, ... just slow progress toward their goal. , Research from reveals ...
(Date:6/24/2016)... Michigan (PRWEB) , ... June 24, 2016 , ... June ... about the dangers associated with chronic pain and the benefits of holistic treatments, ... individuals who are suffering with Sickle Cell Disease. , Sickle Cell Disease (SCD) is ...
(Date:6/24/2016)... (PRWEB) , ... June 24, 2016 , ... Global law ... magazine’s 2016 Legal Elite. The attorneys chosen by their peers for this recognition are ... , Seven Greenberg Traurig Shareholders received special honors as members of this year’s Legal ...
(Date:6/24/2016)... ... June 24, 2016 , ... Topical BioMedics, Inc, makers of Topricin and MyPainAway Pain ... for a minimum wage raise to $12 an hour by 2020 and then adjusting it ... the lost value of the minimum wage, assure the wage floor does not erode again, ...
(Date:6/24/2016)... (PRWEB) , ... June 24, 2016 , ... ... Living, is proud to recognize Dr. Barry M. Weintraub as a prominent plastic ... most beautiful women in the world, and the most handsome men, look naturally ...
Breaking Medicine News(10 mins):